Clinical Trials Logo

Clinical Trial Summary

This study is an epidemiological observational cross-sectional study designed to estimate the prevalence of echocardiographically confirmed RHD in school children from 5-14 years of age in Fiji. The study will be conducted in the Central Division of Fiji within a selection of up to16 primary schools located in the Korovou/Tailevu and Rewa/Nausori sub-divisions. School children will be enrolled after informed consent has been obtained. A standard cardiac examination (auscultation) will be performed as part of the routine annual health check by both school nurses, who have attended a training workshop, and by a paediatrician. All children with or without murmur will have a screening echocardiogram performed at a subsequent visit. Children found to have possible, probable or definite RHD or other cardiac pathology on the screening echocardiogram, will have a full echocardiogram performed by the echocardiography technician at the time of the second study visit. They will all also be referred to a paediatric cardiologist for further investigation and management and monitoring . Cases of RHD will be referred to and followed up by the National Fiji RHD register based at CWMH in Suva.


Clinical Trial Description

n/a


Study Design

Observational Model: Ecologic or Community, Time Perspective: Cross-Sectional


Related Conditions & MeSH terms


NCT number NCT00779662
Study type Observational
Source Queensland Institute of Medical Research
Contact
Status Active, not recruiting
Phase N/A
Start date February 2008
Completion date December 2008

See also
  Status Clinical Trial Phase
Recruiting NCT05991219 - Screening and Secondary Prevention Rheumatic Heart Disease Study
Completed NCT02661763 - Rheumatic Heart Disease Study in Lusaka N/A
Completed NCT02188862 - Genetic Susceptibility to Rheumatic Heart Disease in the Pacific Region N/A
Completed NCT01178710 - Effect of Simvastatin on Cardiac Function N/A
Recruiting NCT05693545 - GOALIE: Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent RHD Trial Phase 2
Terminated NCT03926156 - RIvoraxaban in Mitral Stenosis Phase 3
Not yet recruiting NCT06150274 - Comparison of Wire Assisted Percutaneous Balloon Mitral Valvulotomy With Standard Inoue Balloon Valvulotomy N/A
Recruiting NCT05783375 - Accelerating Delivery of rheUmatic Heart Disease Preventive iNterventions in Northern Uganda N/A
Completed NCT02474108 - Surgical Prevention of Atrial Fibrillation in Patients With Rheumatic Mitral Valve Lesion and Left Atrium Enlargement N/A
Recruiting NCT04556188 - The Clinical Influence of Developing a Sustainable Cardiac Surgery Service to Reduce the Burden of Rheumatic Heart Disease in Sub-Saharan Africa
Recruiting NCT03991910 - The Effect of Ramipril in Suppressing ST2 Expression in Rheumatic Mitral Stenosis Patients Phase 3
Active, not recruiting NCT03346525 - Determining the Impact of Penicillin in Latent RHD: The GOAL Trial Phase 2
Recruiting NCT05504928 - Effectiveness of a School-centered Prevention Program on Prevalence of Latent Rheumatic Heart Disease N/A
Not yet recruiting NCT03549052 - Right Ventricular Echo Assessment in Mitral Valve Replacement
Recruiting NCT05487469 - Thymosin α1 Use in Rheumatic Heart Disease Patients Undergoing Cardiac Surgery on Cardiopulmonary Bypass N/A
Active, not recruiting NCT05276999 - Rheumatic Heart Disease Community Streptococcal Treatment Program "RESET" N/A
Completed NCT05668611 - Train the Trainer Curriculum to Scale up AI Supported Echo for RHD Screening in a Public Health System N/A
Active, not recruiting NCT05211024 - A Long-term Follow up Study for Patients Who Participated in the GOAL Trial (GOAL-Post)
Withdrawn NCT02832531 - INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies, Superiority Phase 3
Completed NCT01794884 - Validity Study of Glutamine to Improve Cardiac Function in Cardiac Surgery Phase 2